Infectious diseases now · 2026
Distribution of anti-diphtheria toxin antibodies in the Italian population by age, sex, and geographic region.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Bagordo Francesco, Panico Alessandra, Grassi Tiziana, Arghittu Antonella, Baldovin Tatjana, Polla Giorgia Della, Massaro Elvira, Montomoli Emanuele, Giacomuzzi Monica, Vitale Francesco, Savio Marta, Gabutti Giovanni, Sero-epidemiological Study Group
Аннотация
OBJECTIVES: Diphtheria incidence has dropped markedly thanks to global vaccination programs, yet some cases still occur even in highly vaccinated countries. We aimed to assess the seroprevalence of anti-diphtheria antibodies in the Italian population by age, sex, and geographical area.
METHODS: Samples were collected from subjects (6-90 years) consulting for routine blood tests. Antibody levels were measured using an immuno-enzymatic assay (seroprotection threshold: 0.01 IU/ml).
RESULTS: Overall, 3,282 serum samples were collected in 2019-2020 from healthy individuals aged 6-90 years residing in 13 Italian regions. Overall, 81.4% of participants showed protective antibody levels. Protection decreased progressively with age: 90.7% among children aged 6-12, 85.4% in those aged 13-24, 78.6% in the 25-39 age group, and 73.2% among 40-64-year-olds. A slight increase was observed in individuals aged ≥ 65 (75.2%). High protection (≥0.1 IU/ml) was most prevalent in the youngest group (78.4%) and declined in older groups, reaching its lowest level in those aged 40-64 (44.7%). Conversely, low protection (<0.1 IU/ml) was highest in participants aged ≥ 65 (30.1%). Males showed significant higher protection than females in the 25-39, 40-64, and ≥ 65 age groups. Geographically, protection levels were higher in Northern (93.4%) and Central Italy (85.6%) than in Southern regions and the Islands (73.8%), for almost all age groups (except 6-12 years).
CONCLUSIONS: Protection against diphtheria in older age groups remains suboptimal. Booster vaccination strategies should be strengthened, as insufficient immunity in adults and the elderly poses a potential risk for severe disease outcomes.
METHODS: Samples were collected from subjects (6-90 years) consulting for routine blood tests. Antibody levels were measured using an immuno-enzymatic assay (seroprotection threshold: 0.01 IU/ml).
RESULTS: Overall, 3,282 serum samples were collected in 2019-2020 from healthy individuals aged 6-90 years residing in 13 Italian regions. Overall, 81.4% of participants showed protective antibody levels. Protection decreased progressively with age: 90.7% among children aged 6-12, 85.4% in those aged 13-24, 78.6% in the 25-39 age group, and 73.2% among 40-64-year-olds. A slight increase was observed in individuals aged ≥ 65 (75.2%). High protection (≥0.1 IU/ml) was most prevalent in the youngest group (78.4%) and declined in older groups, reaching its lowest level in those aged 40-64 (44.7%). Conversely, low protection (<0.1 IU/ml) was highest in participants aged ≥ 65 (30.1%). Males showed significant higher protection than females in the 25-39, 40-64, and ≥ 65 age groups. Geographically, protection levels were higher in Northern (93.4%) and Central Italy (85.6%) than in Southern regions and the Islands (73.8%), for almost all age groups (except 6-12 years).
CONCLUSIONS: Protection against diphtheria in older age groups remains suboptimal. Booster vaccination strategies should be strengthened, as insufficient immunity in adults and the elderly poses a potential risk for severe disease outcomes.